Psychological sequelae and alopecia among women with cancer.
OBJECTIVE
This article reviews the relevant literature on treatment-induced alopecia in women with cancer and describes the development of a computer-assisted intervention to reduce distress associated with this side effect.


METHODS
Alopecia has been cited as the most disturbing anticipated side effect by up to 58% of women preparing for chemotherapy, with 8% being at risk for avoiding treatment. Women with cancer who experience alopecia as a side effect, compared with women with cancer and no alopecia, report lower self-esteem, poorer body image, and lower quality of life. Although physicians' recommendations are the most influential factor on cancer treatment choice, body image and effects on sexuality are the next most influential factors. A study of a computer-imaging intervention, based on concepts related to guided imagery and anticipatory grief, has been launched in an effort to aid women in coping with anticipated treatment-related alopecia.


RESULTS
While we are still waiting for final data collection and analysis from the computer intervention study, the feedback thus far has been positive.


CONCLUSIONS
The intervention described here may prove to be effective in desensitizing women with cancer to hair loss and facilitating an adjustment to self-acceptance. As such, a higher quality of life during the difficult time of coping may be maintained. The development of a computer-imaging intervention offers an opportunity to integrate a standard psychosocial intervention, personalized for each patient, into the routine patient care in the oncology setting.
McGarvey
E L
EL
Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Baum
L D
LD
Pinkerton
R C
RC
Rogers
L M
LM
D000223:Adaptation, Psychological; D000505:Alopecia / Q000139:chemically induced / Q000523:psychology*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D011788:Quality of Life; D014930:Women / Q000523:psychology*
D000970:Antineoplastic Agents